205 related articles for article (PubMed ID: 17002000)
1. The KDOQI clinical practice guidelines and clinical practice recommendations for treating anemia in patients with chronic kidney disease: implications for nurses.
McCarley P
Nephrol Nurs J; 2006; 33(4):423-6, 445; quiz 427-8. PubMed ID: 17002000
[TBL] [Abstract][Full Text] [Related]
2. The new KDOQI clinical practice guidelines and clinical practice recommendations for diabetes and CKD.
Nelson RG; Tuttle KR
Blood Purif; 2007; 25(1):112-4. PubMed ID: 17170547
[TBL] [Abstract][Full Text] [Related]
3. NKF-DOQI clinical practice guidelines for the treatment of anemia of chronic renal failure. National Kidney Foundation-Dialysis Outcomes Quality Initiative.
Am J Kidney Dis; 1997 Oct; 30(4 Suppl 3):S192-240. PubMed ID: 9339151
[No Abstract] [Full Text] [Related]
4. Should we limit the ferritin upper threshold to 500 ng/ml in CKD patients?
Dukkipati R; Kalantar-Zadeh K
Nephrol News Issues; 2007 Jan; 21(1):34-8. PubMed ID: 17269263
[TBL] [Abstract][Full Text] [Related]
5. Improving management of anemia using CQI techniques.
Berns JS; Cahill C; Okupinski V; O'Neill K
Nephrol News Issues; 1997 Sep; 11(9):11-3. PubMed ID: 9348865
[TBL] [Abstract][Full Text] [Related]
6. Renal anemia: comparing current Eastern and Western European management practice (ORAMA).
Wiecek A; Covic A; Locatelli F; Macdougall IC;
Ren Fail; 2008; 30(3):267-76. PubMed ID: 18350446
[TBL] [Abstract][Full Text] [Related]
7. Updating practices in an evolving IV iron and anemia environment: practical solutions.
Amerling R; Easom A; Juergensen P
Nephrol Nurs J; 2007; 34(5):533-41; quiz 542-3. PubMed ID: 18041456
[TBL] [Abstract][Full Text] [Related]
8. Optimizing anemia management in hospitalized patients with end-stage renal disease.
Heung M; Mueller BA; Segal JH
Ann Pharmacother; 2009 Feb; 43(2):276-82. PubMed ID: 19141655
[TBL] [Abstract][Full Text] [Related]
9. [Regarding the optimal hemoglobin target range in renal anemia].
Maurin N
Med Klin (Munich); 2008 Sep; 103(9):633-7. PubMed ID: 18813886
[TBL] [Abstract][Full Text] [Related]
10. The optimal hemoglobin in dialysis patients- a critical review.
Singh AK; Fishbane S
Semin Dial; 2008; 21(1):1-6. PubMed ID: 18251947
[TBL] [Abstract][Full Text] [Related]
11. The role of erythropoiesis-stimulating agents in the treatment of anemia.
Fishbane S
Am J Manag Care; 2010 Mar; 16 Suppl Issues():S67-73. PubMed ID: 20297874
[TBL] [Abstract][Full Text] [Related]
12. The controversy surrounding hemoglobin and erythropoiesis-stimulating agents: what should we do now?
Singh AK
Am J Kidney Dis; 2008 Dec; 52(6 Suppl):S5-13. PubMed ID: 19010260
[TBL] [Abstract][Full Text] [Related]
13. KDOQI US commentary on the KDIGO clinical practice guideline for the prevention, diagnosis, evaluation, and treatment of hepatitis C in CKD.
Gordon CE; Balk EM; Becker BN; Crooks PA; Jaber BL; Johnson CA; Michael MA; Pereira BJ; Uhlig K; Levin A
Am J Kidney Dis; 2008 Nov; 52(5):811-25. PubMed ID: 18971009
[TBL] [Abstract][Full Text] [Related]
14. Clinical practice guidelines for bone metabolism and disease in chronic kidney disease: an overview.
Bailie GR; Massry SG;
Pharmacotherapy; 2005 Dec; 25(12):1687-707. PubMed ID: 16305288
[TBL] [Abstract][Full Text] [Related]
15. The challenges of using serum ferritin to guide i.v. iron treatment practices in patients on hemodialysis with anemia.
Easom A
Nephrol Nurs J; 2006; 33(5):543-51; quiz 552-3. PubMed ID: 17044438
[TBL] [Abstract][Full Text] [Related]
16. Real-world doxercalciferol treatment in SHPT CKD stage 3 and 4: an analysis of change in iPTH and accordance to KDOQI recommendations.
Kumar N; Lindberg J; David K; Morris J; Menoyo J
Am J Nephrol; 2009; 29(2):71-8. PubMed ID: 18689981
[TBL] [Abstract][Full Text] [Related]
17. Limiting iron supplementation for anemia in dialysis patients--the Basis for Japan's conservative guidelines.
Yamamoto H; Tsubakihara Y
Semin Dial; 2011; 24(3):269-71. PubMed ID: 21682768
[TBL] [Abstract][Full Text] [Related]
18. Impact of the Kidney Disease Outcomes Quality Initiative (KDOQI) Clinical Practice Guidelines for Bone Metabolism and Disease in a large dialysis network.
Wald R; Tentori F; Tighiouart H; Zager PG; Miskulin DC
Am J Kidney Dis; 2007 Feb; 49(2):257-66. PubMed ID: 17261428
[TBL] [Abstract][Full Text] [Related]
19. KDOQI Clinical Practice Guideline and Clinical Practice Recommendations for anemia in chronic kidney disease: 2007 update of hemoglobin target.
KDOQI
Am J Kidney Dis; 2007 Sep; 50(3):471-530. PubMed ID: 17720528
[No Abstract] [Full Text] [Related]
20. Stabilizing hemoglobin levels: what's new in IV iron and anemia management?
Fishbane S; Larson K; VanBuskirk S
Nephrol Nurs J; 2008; 35(5):493-502. PubMed ID: 18856080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
